BiotechTube
Cetylite Industries

Cetylite Industries

Pennsauken, United States· Est. 1945

Founded in 1945, Cetylite Industries is a privately-held, specialty manufacturer focused on patient comfort, safety, and satisfaction. The company's expertise lies in the formulation, packaging, and distribution of chemistry-based products, operating from a 31,700 sq. ft. CGMP-compliant facility in Pennsauken, New Jersey. With a diverse portfolio of prescription topical anesthetics and infection protection products distributed through a large national network, Cetylite maintains a strong legacy of quality and innovation while remaining a family-run business. Its success is built on a 65+ year record of safety, dependability, and regulatory compliance.

cetylite.com

Private Company

Total funding raised: $15M

AI Company Overview

Founded in 1945, Cetylite Industries is a privately-held, specialty manufacturer focused on patient comfort, safety, and satisfaction. The company's expertise lies in the formulation, packaging, and distribution of chemistry-based products, operating from a 31,700 sq. ft. CGMP-compliant facility in Pennsauken, New Jersey. With a diverse portfolio of prescription topical anesthetics and infection protection products distributed through a large national network, Cetylite maintains a strong legacy of quality and innovation while remaining a family-run business. Its success is built on a 65+ year record of safety, dependability, and regulatory compliance.

AnesthesiaInfection ControlDental Care

Technology Platform

Specialized chemical formulation and integrated CGMP manufacturing for topical anesthetics and high-level disinfectants, with proprietary concentrate technology dating to 1955.

Funding History

1
Total raised:$15M
Debt$15MMay 15, 2020

Opportunities

Opportunities include leveraging its 70-year gold-standard reputation to expand its product portfolio, deepening sales through its extensive national distributor network, and potentially exploring international markets.
The sustained focus on infection control post-pandemic also presents a tailwind for its Cetylcide product line.

Risk Factors

Key risks include regulatory challenges from the FDA or EPA, competition from larger, well-capitalized corporations, supply chain and raw material cost pressures, and succession planning as a third-generation family business.

Competitive Landscape

Cetylite competes with large pharma/medtech firms (e.g., 3M, Ecolab) in infection control and other specialty pharma in topical anesthetics. Its differentiation lies in its family-owned agility, vertical integration, 70-year reputation for quality, and unique dual focus on both prescription anesthetics and EPA-registered disinfectants.